Definium Therapeutics, Inc. (DFTX)

Typically moves ±5.49% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-08-13 APPROXIMATE

Since Mar 28, 2022, Definium Therapeutics, Inc. (DFTX) has reported earnings 18 times. On average the shares move ±5.49% post-earnings, with a positive reaction 55.6% of the time. Its largest post-earnings gain was +14.44% (Nov 02, 2023) and its largest decline was -7.64% (Aug 03, 2023). The next earnings report is predicted for 2026-08-13 (approximate).

Earnings reactions

How DFTX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±5.49%

Positive %

55.6%

Negative %

44.4%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
May 07, 2026	☽ POST	-5.03%	open_in_new
Feb 26, 2026	☽ POST	+0.93%	open_in_new
Nov 06, 2025	☽ POST	+3.17%	open_in_new
Jul 31, 2025	☽ POST	-7.15%	open_in_new
May 08, 2025	☀ PRE	-1.97%	open_in_new
Mar 06, 2025	☀ PRE	+3.61%	open_in_new
Nov 07, 2024	☽ POST	+12.9%	open_in_new
Aug 13, 2024	☀ PRE	-3.8%	open_in_new
May 08, 2024	☽ POST	-5.1%	open_in_new
Feb 28, 2024	☀ PRE	-3.78%	open_in_new
Nov 02, 2023	☽ POST	+14.44%	open_in_new
Aug 03, 2023	☽ POST	-7.64%	open_in_new
May 17, 2023	☽ POST	+0%	open_in_new
Mar 09, 2023	☽ POST	-5.35%	open_in_new
Nov 10, 2022	☀ PRE	+7.88%	open_in_new
Aug 11, 2022	☽ POST	+11.69%	open_in_new
May 16, 2022	☀ PRE	+2.69%	open_in_new
Mar 28, 2022	☽ POST	+1.72%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.49%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 20 →

Funds holding

$361300622

Total value held

Buying

20 added · 0 reduced

Blackrock, Inc.

$160276347 NEW BUY

Janus Henderson Group Plc

$67226955 NEW BUY

State Street Corp

$46718400 NEW BUY

Goldman Sachs Group Inc

$31665268 NEW BUY

Northern Trust Corp

$15100854 NEW BUY

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260626	open_in_new SEC.gov
4	20260626	open_in_new SEC.gov
4	20260626	open_in_new SEC.gov
4	20260626	open_in_new SEC.gov
4	20260626	open_in_new SEC.gov
144	20260625	open_in_new SEC.gov
144	20260625	open_in_new SEC.gov
144	20260625	open_in_new SEC.gov
144	20260625	open_in_new SEC.gov
144	20260625	open_in_new SEC.gov

Frequently asked about DFTX earnings

When does Definium Therapeutics, Inc. report earnings next? expand_more

Definium Therapeutics, Inc. (DFTX)'s next earnings date is approximate for 2026-08-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does DFTX stock move after earnings? expand_more

Over 18 reports, DFTX has moved an average of ±5.49% the session after earnings, closing higher 55.6% of the time.

What was DFTX's biggest post-earnings move? expand_more

DFTX's largest post-earnings gain on record was +14.44% on Nov 02, 2023, and its largest decline was -7.64% on Aug 03, 2023.

Where can I find Definium Therapeutics, Inc.'s SEC filings? expand_more

All of Definium Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.